Showing results (51-60 of 388) with videos related to

Sort By:
Pageof 39
European Journal of Cancer (Oxford, England : 1990)|July 10, 2012
Patterns of deregulation of insulin growth factor signalling pathway in paediatric and adult gastrointestinal stromal tumoursAntoine Italiano, Junwei Chen, Lei Zhang, et al.
Annals of Surgery|April 17, 2007
Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumorRonald P DeMatteo, Robert G Maki, Samuel Singer, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 22, 2004
Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastasesStephen R Grobmyer, Yuman Fong, Michael D'Angelica, et al.
Journal of the American College of Surgeons|March 25, 2016
Outcomes of the Memorial Sloan Kettering Cancer Center International General Surgical Oncology FellowshipIsmael Dominguez-Rosado, Vitor Moutinho, Ronald P DeMatteo, et al.
The Journal of Clinical Investigation|January 23, 2010
Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretionZubin M Bamboat, Lee M Ocuin, Vinod P Balachandran, et al.
Hepatology (Baltimore, Md.)|January 30, 2007
Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansionT Peter Kingham, Umer I Chaudhry, George Plitas, et al.
Annals of Surgical Oncology|November 6, 2008
Analysis of the extent of resection for adenocarcinoma of the gallbladderMichael D'Angelica, Kimberly Moore Dalal, Ronald P DeMatteo, et al.
Hepatology (Baltimore, Md.)|November 11, 2009
Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injuryZubin M Bamboat, Vinod P Balachandran, Lee M Ocuin, et al.
Human Immunology|July 22, 2008
Circulating HLA-DR(+) natural killer cells have potent lytic ability and weak antigen-presenting cell functionBryan M Burt, George Plitas, Hoang M Nguyen, et al.
Journal of the American College of Surgeons|March 31, 2004
Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancerMichael D'Angelica, Robert C G Martin, William R Jarnagin, et al.
Pageof 39